Novocure Ltd (NVCR)

03:20 AM

NovoCure Ltd (NVCR) Stock: 52-Week Performance Insights and Trading Volume - investchronicle.com

03:20 AM

10:19 AM

Novocure stock hits 52-week low at 14.17 USD - Investing.com Australia

10:19 AM

09:51 AM

Novocure Ltd reports results for the quarter ended June 30Earnings Summary - TradingView

09:51 AM

09:21 AM

Novocure: Steady Ahead of Key Milestones - The Motley Fool

09:21 AM

08:05 AM

NovoCure (NVCR) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance

08:05 AM

07:32 AM

NovoCure Ltd Q2 2025 Earnings: EPS Loss of $0.36 Beats Estimates - GuruFocus

07:32 AM

07:16 AM

Novocure Ltd earnings beat by $0.02, revenue topped estimates - Investing.com South Africa

07:16 AM

07:03 AM

NovoCure Ltd SEC 10-Q Report - TradingView

07:03 AM

07:00 AM

Novocure Reports Second Quarter 2025 Financial Results - Stock Titan

07:00 AM

Jul 23, 2025

What analysts say about NovoCure Limited stockBreakthrough wealth creation - Autocar Professional

Jul 23, 2025

Jul 20, 2025

What drives NovoCure Limited stock priceRobust investment performance - jammulinksnews.com

Jul 20, 2025

Jul 19, 2025

Is NovoCure Limited a good long term investmentUnmatched market gains - jammulinksnews.com

Jul 19, 2025

Jul 19, 2025

M&T Bank Corp Sells 1,750 Shares of NovoCure Limited (NASDAQ:NVCR) - Defense World

Jul 19, 2025

Jul 18, 2025

NovoCure Limited Stock Analysis and ForecastExplosive portfolio gains - jammulinksnews.com

Jul 18, 2025

Jul 16, 2025

How NovoCure Limited stock performs during market volatilityBreakout Level Watch - Newser

Jul 16, 2025

Jul 15, 2025

What makes NovoCure Limited stock price move sharplyFree Stock Market Group - Newser

Jul 15, 2025

Jul 15, 2025

Why NovoCure Limited stock attracts strong analyst attentionFast Growing Stocks - Newser

Jul 15, 2025

Jul 14, 2025

NovoCure (NASDAQ:NVCR) shareholders are up 4.2% this past week, but still in the red over the last three years - simplywall.st

Jul 14, 2025

Jul 14, 2025

Teacher Retirement System of Texas Buys 3,123 Shares of NovoCure Limited (NASDAQ:NVCR) - Defense World

Jul 14, 2025

Jul 14, 2025

Most Volatile Stocks in the US (July 2025) - Investing.com

Jul 14, 2025

Jul 11, 2025

NovoCure Ltd Stock Price Falls 3.41% Amid Analyst Predictions of 81.88% Upside - AInvest

Jul 11, 2025

Jul 10, 2025

LADENBURG THALM/SH SH Initiates Coverage on NovoCure (NASDAQ:NVCR) - Defense World

Jul 10, 2025

Jul 08, 2025

NovoCure stock initiated with Buy rating at Ladenburg Thalmann By Investing.com - Investing.com South Africa

Jul 08, 2025

Jul 08, 2025

This Circle Internet Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Tuesday - Benzinga

Jul 08, 2025

Jul 08, 2025

NovoCure stock initiated with Buy rating at Ladenburg Thalmann - Investing.com

Jul 08, 2025

Jul 03, 2025

NovoCure stock maintains Buy rating at H.C. Wainwright on positive cancer trial data - Investing.com Nigeria

Jul 03, 2025

Jul 01, 2025

New Clinical Data: Revolutionary Cancer Therapy Cuts Pancreatic Cancer Pain by 47%, Delays Opioid Use - Stock Titan

Jul 01, 2025

Jun 30, 2025

Novocure to Present Final Secondary Endpoint Data from the Phase - GuruFocus

Jun 30, 2025

Jun 30, 2025

NVCR SEC FilingsNovocure 10-K, 10-Q, 8-K Forms - Stock Titan

Jun 30, 2025

Jun 30, 2025

Novocure to Report Second Quarter 2025 Financial Results | NVCR Stock News - GuruFocus

Jun 30, 2025

Jun 29, 2025

NovoCure Limited (NASDAQ:NVCR) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World

Jun 29, 2025

Jun 27, 2025

Demystifying NovoCure: Insights From 4 Analyst Reviews - Nasdaq

Jun 27, 2025

Jun 18, 2025

NovoCure Limited's (NASDAQ:NVCR) P/S Still Appears To Be Reasonable - simplywall.st

Jun 18, 2025

Jun 16, 2025

Rhumbline Advisers Has $2.69 Million Stock Position in NovoCure Limited (NASDAQ:NVCR) - Defense World

Jun 16, 2025

Jun 12, 2025

Novocure’s SWOT analysis: innovative cancer therapy firm faces growth hurdles By Investing.com - Investing.com South Africa

Jun 12, 2025

Jun 12, 2025

Novocure’s SWOT analysis: innovative cancer therapy firm faces growth hurdles - Investing.com India

Jun 12, 2025

Jun 06, 2025

NovoCure Ltd (NVCR) Shares Up 4.08% on Jun 6 - GuruFocus

Jun 06, 2025

Jun 06, 2025

NVCR Stock Dips Despite Positive OS Data From Phase 3 PANOVA-3 Trial - TradingView

Jun 06, 2025

Jun 06, 2025

Mackenzie Financial Corp Purchases Shares of 6,820 NovoCure Limited (NASDAQ:NVCR) - Defense World

Jun 06, 2025

Jun 05, 2025

Insider Sell Alert: Frank Leonard Sells 30,196 Shares of NovoCure Ltd (NVCR) - GuruFocus

Jun 05, 2025

Jun 04, 2025

Novocure at Jefferies Conference: Expanding Horizons in Cancer Treatment - Investing.com

Jun 04, 2025

Jun 03, 2025

Ameriprise Financial Inc. Has $682,000 Position in NovoCure Limited (NASDAQ:NVCR) - Defense World

Jun 03, 2025

Jun 02, 2025

H.C. Wainwright reiterates Buy rating on NovoCure stock after ASCO data - Investing.com Nigeria

Jun 02, 2025

Jun 02, 2025

NovoCure Ltd (NVCR) Shares Down 7.43% on Jun 2 - GuruFocus

Jun 02, 2025

Jun 02, 2025

NovoCure's Tumor Treating Fields Boost One-Year And Pain-Free Survival In Pancreatic Cancer Trial - Yahoo Finance

Jun 02, 2025

Jun 02, 2025

Novocure (NVCR) Gains Support for Future Launch from Promising T - GuruFocus

Jun 02, 2025

Jun 02, 2025

Novocure (NVCR) Gains Support for Future Launch from Promising Trial Outcomes | NVCR Stock News - GuruFocus

Jun 02, 2025

Jun 02, 2025

H.C. Wainwright reiterates Buy rating on NovoCure stock after ASCO data By Investing.com - Investing.com South Africa

Jun 02, 2025

Jun 01, 2025

Novocure (NVCR) Announces Positive Phase 3 Trial Results for Pancreatic Cancer Therapy | NVCR Stock News - GuruFocus

Jun 01, 2025